| Description | Isotaxiresinol prevents d-GalN/LPS-induced hepatic injury by inhibiting hepatocyte apoptosis through the blocking of TNF-alpha and IFN-gamma production by activated macrophages and direct inhibition of the apoptosis induced by TNF-alpha. Isotaxiresinol may be useful for treatment of postmenopausal osteoporosis, especially for prevention of bone fracture induced by estrogen deficiency. |
| molecular weight | 346.37 |
| Molecular formula | C19H22O6 |
| CAS | 26194-57-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |